UBS Maintains Neutral on Corteva, Lowers Price Target to $85
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $89 to $85.
Read original at benzingaStocks · News reference
8-K filing — Corteva, Inc. (CTVA)
Filed: 2026-08-20 AccNo: 0001193125-26-358064 Size: 230 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 20, 2026, 12:00 PM
- Checked
- Aug 20, 2026, 12:00 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
UBS Maintains Neutral on Corteva, Raises Price Target to $89
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $86 to $89.
Read original at benzingaCitigroup Maintains Neutral on Corteva, Raises Price Target to $86
Citigroup analyst Patrick Cunningham maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $85 to $86.
Read original at benzinga